Paiva-Fonseca F, de-Almeida OP, Ayroza-Rangel ALC,
Agustin-Vargas P. Tissue microarray construction for salivary gland tumors
study. Med Oral Patol Oral
Cir Bucal. 2013 Jan 1;18 (1):e1-6.
doi:10.4317/medoral.18204
http://dx.doi.org/doi:10.4317/medoral.18204
|
1. Yamazaki M, Fujii S, Murata Y, Hayashi R,
Ochiai A. High expression level of geminin predicts a poor clinical outcome in salivary
gland carcinomas. Histopathology. 2010;56:883-92. |
|
|
|
|
|
2.Vargas PA, Gerhard R, Araújo Filho VJ, de Castro IV. Salivary gland tumors in a Brazilian
Population: A retrospective study of 124 cases. Rev Hosp Clin
Fac Med Sao Paulo. 2002;57:271-6. |
|
|
|
|
|
3.Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, et al.
Tissue microarray for rapid linking of molecular changes to clinical
endpoints. Am J Pathol.
2001;159:2249-56. |
|
|
|
|
|
4. Simon R, Sauter G. Tissue microarrays for
miniaturized high-throughput molecular profiling of tumors. Exp Hematol. 2002;30:1365-72. |
|
|
|
|
|
5. Kononen J, Bubendorf
L, Kallioniemi A, Bärlund
M, Schraml P, Leighton S, et al. Tissue microarrays
for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-7. |
|
|
|
|
|
6. Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen
MW. Tissue microarray – a high-throughput molecular analysis in head and neck
cancer. J Oral Pathol Med. 2008;37:166-76. |
|
|
|
|
|
7. Nocito A, Kononen
J, Kallioniemi OP, Sauter
G. Tissue microarrays (TMAs) for high-throughput molecular pathology
research. Int J Cancer. 2001;94:1-5. |
|
|
|
|
|
8. Voduc D, Kenney C, Nielsen TO. Tissue
microarrays in clinical oncology. Semin Radiat Oncol. 2008;18:89-97. |
|
|
|
|
|
9. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue
microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001;10:657-62. |
|
|
|
|
|
10. Henriksen
KL, Rasmussen BB, Lykkesfeldt
AE, Møller S, Ejlertsen
B, Mouridsen HT. Semi-quantitative scoring of
potentially predictive markers for endocrine treatment of breast cancer: a
comparison between whole sections and tissue microarrays. J Clin Pathol. 2007;60:397-404. |
|
|
|
|
|
11. Alkushi A. Validation of tissue
microarray biomarker expression of breast carcinomas in Saudi women. Hematol Oncol Stem
Cell Ther. 2009;2:394-8. |
|
|
|
|
|
12. Chen WC, Lin MS, Zhang BF, Fang J, Zhou Q, Hu
Y, et al. Survey of molecular profiling during human
colon cancer development and progression by immunohistochemical
staining on tissue microarray. World J
Gastroenterol. 2007;13:699-708. |
|
|
|
|
|
13. Fons
G, Hasibuan SM, van der Velden
J, ten Kate FJ. Validation of tissue microarray technology in endometrioid
cancer of the endometrium. J Clin
Pathol. 2007;60:500-3. |
|
|
|
|
|
14. Boone J, van Hillegersberg R, van Diest PJ, Offerhaus GJ, Rinkes IH, Kate FJ. Validation
of tissue microarray technology in squamous cell
carcinoma of the esophagus. Virchows Arch. 2008;452:507-14. |
|
|
|
|
|
15. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK. Expression of p53, pRB, and p16 in lung tumours: a
validation study on tissue microarrays. J
Pathol. 2003;200:610-9. |
|
|
|
|
|
16. Tawfik El-Mansi
M, Williams AR. Validation of tissue microarray technology using cervical adenocarcinoma and its precursors as a model system. Int J Gynecol Cancer. 2006;16:1225-33. |
|
|
|
|
|
17. Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J. Validation of tissue
microarray technology in ovarian carcinoma. Mod Pathol. 2004;17:790-7. |
|
|
|
|
|
18. Iwafuchi H, Mori N, Takahashi T, Yatabe Y. Phenotypic composition of salivary gland
tumors: an application of principle component analysis to tissue microarray
data. Mod Pathol. 2004;17:803-10. |
|
|
|
|
|
19. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM. Expression
of Mcm-2, Ki-67 and geminin in benign and malignant
salivary gland tumours. J Oral Pathol
Med. 2008;37:309-18. |
|
|
|
|
|
20. Vargas PA, Speight PM, Bingle CD,
Barrett AW, Bingle L. Expression of PLUNC family
members in benign and malignant salivary gland tumours.
Oral Dis.
2008;14:613-9. |
|
|
|
|
|
21. Freier K, Flechtenmacher
C, Walch A, Devens F, Mühling J, Lichter P, et al.
Differential KIT expression in histological subtypes of adenoid cystic
carcinoma (ACC) of the salivary gland. Oral
Oncol. 2005;41:934-9. |
|
|
|
|
|
22. Freier K, Flechtenmacher
C, Walch A, Ohl S, Devens F, Burke B, et al. Copy number gains on 22q13 in
adenoid cystic carcinoma of the salivary gland revealed by comparative
genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005;159:89-95. |
|
|
|
|
|
23. Clauditz TS, Reiff
M, Gravert L, Gnoss A, Tsourlakis MC, Münscher A, et al.
Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Pathology. 2011;43:459-64. |
|
|
|
|
|
24. Heiduschka G, Erovic
BM, Pammer J, Kotowski U,
Kaider A, Ch Grasl M, et
al. Mcl-1 expression is up-regulated in malignancies of the parotid gland. Dis Markers. 2011;30:229-33. |
|
|
|
|
|
25. Williams MD, Roberts DB, Kies MS, Mao L,
Weber RS, El-Naggar AK. Genetic and expression
analysis of HER-2 and EGFR genes in salivary duct carcinoma: Empirical and
therapeutic significance. Clin Cancer
Res. 2010;16:2266-74. |
|
|
|
|
|
26. Goldstine J, Seligson
DB, Beizai P, Miyata H, Vinters
HV. Tissue microarrays in the study of non-neoplastic
disease of the nervous system. J Neuropathol Exp Neurol. 2002;61:653-62. |
|
|
|
|
|
27. Hager M, Kolbitsch C, Tiefenthaler W, Haufe H, Kemmerling R, Lucia Moser P. Tissue microarrays from
renal cell tumors: exclusion criteria and rate of exclusion. Scand J Urol Nephrol. 2007;41:485-9. |
|